Over the last 12 months, Gilead Sciences insiders reported no purchases and 9 sales totaling $7.3M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | O'Day Daniel PatrickChairman & CEO · O·D | ▼ Sale | 15,000 | $130.31 | $2.0M | -2.5% | plan · 3 tranches |
| Jul 15, 2026 | Dickinson Andrew DChief Financial Officer · O | ▼ Sale | 3,000 | $129.93 | $390K | -1.7% | plan |
| Jul 15, 2026 | Mercier JohannaChief Comm & Corp Aff Officer · O | ▼ Sale | 3,000 | $129.92 | $390K | -2.4% | plan |
| Jul 1, 2026 | O'Day Daniel PatrickChairman & CEO · O·D | ▼ Sale | 15,000 | $126.29 | $1.9M | -2.4% | plan · 2 tranches |
| Jun 15, 2026 | Mercier JohannaChief Comm & Corp Aff Officer · O | ▼ Sale | 3,000 | $123.92 | $372K | -2.4% | plan · 3 tranches |
| Jun 15, 2026 | Dickinson Andrew DChief Financial Officer · O | ▼ Sale | 3,000 | $125.4 | $376K | -1.7% | plan |
| Jun 1, 2026 | O'Day Daniel PatrickChairman & CEO · O·D | ▼ Sale | 1,038 | $132.97 | $138K | -0.2% | plan |
| Jun 1, 2026 | O'Day Daniel PatrickChairman & CEO · O·D | ▼ Sale | 3,062 | $132.22 | $405K | -0.5% | plan |
| Jun 1, 2026 | O'Day Daniel PatrickChairman & CEO · O·D | ▼ Sale | 10,900 | $131.1 | $1.4M | -1.7% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $GILD feed.